Scientists extracted 39,000-year-old RNA from a frozen woolly mammoth, revealing which genes were active when it died.

Scribe Therapeutics Inc. ("Scribe"), a genetic medicines company pioneering next-generation in vivo CRISPR-based medicines designed to be safe, durable, and effective enough to become standard-of-care ...

Metagenomi, Inc. (Nasdaq: MGX) (the 'Company”), an in vivo genome editing company capitalizing on its proprietary ...

Detailed price information for Prime Medicine Inc (PRME-Q) from The Globe and Mail including charting and trades.